Vaccine-maker Bharat Biotech claimed that with several hundred million doses administered worldwide, Covaxin has demonstrated an excellent safety record with minimal adverse events and no vaccine associated cases detected for myocarditis or thrombocytopenia
India’s coronavirus infections rose by another 62,212 cases over the previous day and a local media report said on Saturday that the government had begun identifying about 300 million people who would be given the vaccine first when it is ready.
The Times of India said that frontline health and sanitation workers, police officials and elderly people with co-morbidities will get the vaccine on priority.
The plan, which is still in the draft stage, aims to cover 23% of the population in the first phase. The final plan is likely to be ready by end October-November, the report said.
Delhi’s air may be growing more toxic by the day — but on Sunday, authorities appeared to view a peaceful…
The 14th State Level Philatelic Exhibition, MAPPEX-2025, organized by the Madhya Pradesh Postal Circle, was held in Bhopal from November…
South Asia accounts for 50% of the groundwater pumped for irrigation globally. The practice has been critical to ensuring food…
Earlier this week, news came in that ousted Bangladesh Prime Minister Sheikh Hasina has been sentenced to death – by…
At the 14th edition of the Dharamshala International Film Festival, three documentaries stood out for the way they portrayed the…
The Special Intensive Revision of the voters list across 12 Indian states could potentially lead to sharpening of the communal…
This website uses cookies.